Neuroendocrine prostate carcinoma cells originate from the p63-expressing basal cells but not the pre-existing adenocarcinoma cells in mice

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer

(2017) Min Zou et al.   Cancer Discovery

Integrating outpatient palliative care into a metastatic breast oncology clinic.

(2015) Rebecca Small et al.   JOURNAL OF CLINICAL ONCOLOGY

Aggressive Variants of Castration-Resistant Prostate Cancer

(2014) H. Beltran et al.   CLINICAL CANCER RESEARCH

The Steroid Receptor Coactivator-3 Is Required for Developing Neuroendocrine Tumor in the Mouse Prostate

(2014) Jean Ching-Yi Tien et al.   International Journal of Biological Sciences

The Prostate Basal Cell (BC) Heterogeneity and the p63-Positive BC Differentiation Spectrum in Mice

(2014) Dong-Kee Lee et al.   International Journal of Biological Sciences

Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST)

(2014) Yezi Zhu et al.   PROSTATE

REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer

(2013) C. Svensson et al.   NUCLEIC ACIDS RESEARCH

Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer

(2009) Ganesh S. Palapattu et al.   PROSTATE